RecruitingPhase 2NCT03999723

Combining Active and Passive DNA Hypomethylation

Studying Acute myelomonocytic leukemia

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Kirsten Grønbæk
Principal Investigator
Kirsten Grønbæk, Prof., MD
Rigshospitalet, Denmark
Intervention
Vitamin C(dietary_supplement)
Enrollment
196 enrolled
Eligibility
18 years · All sexes
Timeline
2019 – 2027

Study locations (10)

Collaborators

Van Andel Institute - Stand Up To Cancer Epigenetics Dream Team · Karolinska University Hospital · Skane University Hospital · Sahlgrenska University Hospital · University of Southern California · Imperial College London · University of Copenhagen · Zealand University Hospital · Aalborg University Hospital · Odense University Hospital · Technical University of Denmark · Aarhus University Hospital · Uppsala University Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03999723 on ClinicalTrials.gov

Other trials for Acute myelomonocytic leukemia

Additional recruiting or active studies for the same condition.

See all trials for Acute myelomonocytic leukemia →

← Back to all trials